Literature DB >> 1168251

Blockade by narcotic drugs of naloxone-precipitated jumping in morphine-dependent mice.

L C Iorio, M A Deacon, E A Ryan.   

Abstract

A dose regimen for administration of morphine, test drugs with potential to cause physical dependence and naloxone was determined to allow within one experimental day acquisition of morphine-dependent mice and evaluation of the narcotic drugs for their ability to prevent naloxone-precipitated jumping. This test procedure can be used to assess capacity of unknown drugs to suppress morphine withdrawal symptoms; the mechanism of suppression can be subsequently determined in secondary tests. However, for known morphine-like analgesics, the test procedure appears to reliably assess physical dependence properties. The results obtained on subcutaneous administration of five selected narcotic drugs and apomorphine show that their order of potency was methadone greater than meperidine equal apomorphine greater than d-propoxyphene greater than pentazocine. Codeine, also tested subcutaneously, did not substitute at sublethal doses. Except for apomorphine, which might have masked naloxone-precipitated jumping by inducing behavioral aggression, the order of potency compares favorably with the degree of physical dependence reported in humans. Thus, the described procedure might be employed to evaluate morphine substitution and hence potential physical dependence liability of unknown narcotic-like analgesics.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1168251

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  4 in total

1.  Effect of apomorphine on the antinociceptive activity of morphine.

Authors:  Z Dunai-Kovács; J I Székely
Journal:  Psychopharmacology (Berl)       Date:  1977-06-06       Impact factor: 4.530

2.  Differential effects of endocannabinoid catabolic inhibitors on morphine withdrawal in mice.

Authors:  Thomas F Gamage; Bogna M Ignatowska-Jankowska; Pretal P Muldoon; Benjamin F Cravatt; M Imad Damaj; Aron H Lichtman
Journal:  Drug Alcohol Depend       Date:  2014-11-26       Impact factor: 4.492

3.  Extracellular signal-regulated kinase activation in the amygdala mediates elevated plus maze behavior during opioid withdrawal.

Authors:  Rebecca S Hofford; Stephen R Hodgson; Kris W Roberts; Camron D Bryant; Christopher J Evans; Shoshana Eitan
Journal:  Behav Pharmacol       Date:  2009-10       Impact factor: 2.293

4.  Naloxone-precipitated withdrawal as a function of the morphine-naloxone interval.

Authors:  M A Linseman
Journal:  Psychopharmacology (Berl)       Date:  1977-10-20       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.